Search

Author/Creator Yamaji, Maiko

1. Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastoma. Issue 1 (14th December 2015)

Authors:
Scholz, Alexander; Harter, Patrick N; Cremer, Sebastian; Yalcin, Burak H; Gurnik, Stefanie; Yamaji, Maiko; Di Tacchio, Mariangela; Sommer, Kathleen; Baumgarten, Peter; Bähr, Oliver; Steinbach, Joachim P; Trojan, Jörg; Glas, Martin; Herrlinger, Ulrich; Krex, Dietmar; Meinhardt, Matthias; Weyerbroc...
Journal:
EMBO molecular medicine
Issue:
Volume 8:Issue 1(2016)
Page Start:
39
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. VEGF (Vascular Endothelial Growth Factor) Induces NRP1 (Neuropilin-1) Cleavage via ADAMs (a Disintegrin and Metalloproteinase) 9 and 10 to Generate Novel Carboxy-Terminal NRP1 Fragments That Regulate Angiogenic Signaling. Issue 8 (August 2018)

Authors:
Mehta, Vedanta; Fields, Laura; Evans, Ian M.; Yamaji, Maiko; Pellet-Many, Caroline; Jones, Timothy; Mahmoud, Marwa; Zachary, Ian
Journal:
Arteriosclerosis, thrombosis, and vascular biology
Issue:
Volume 38:Issue 8(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗